Common Stock, Shares, Outstanding of Intellia Therapeutics, Inc. from 31 Dec 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Intellia Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2015 to 31 Dec 2025.
  • Intellia Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 116,317,060, a 14% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Intellia Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 116,317,060 +14,287,466 +14% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 115,787,285 +13,990,920 +14% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 105,330,693 +7,041,543 +7.2% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 103,539,685 +7,206,312 +7.5% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 102,029,594 +9,032,436 +9.7% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 101,796,365 +12,698,544 +14% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 98,289,150 +9,941,516 +11% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 96,333,373 +8,237,594 +9.4% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 92,997,158 +5,894,151 +6.8% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 89,097,821 +12,509,874 +16% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 88,347,634 +12,346,889 +16% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 88,095,779 +12,471,612 +16% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 87,103,007 +12,617,124 +17% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 76,587,947 +2,245,769 +3% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 76,000,745 +7,668,965 +11% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 75,624,167 +7,733,833 +11% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 74,485,883 +8,251,827 +12% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q3 2021 74,342,178 +15,549,966 +26% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 68,331,780 +9,607,542 +16% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 67,890,334 +17,287,459 +34% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 66,234,056 +16,036,012 +32% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 58,792,212 +9,914,915 +20% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 58,724,238 +11,009,663 +23% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 50,602,875 +5,123,777 +11% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 50,198,044 +4,973,564 +11% 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q3 2019 48,877,297 +5,507,974 +13% 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 47,714,575 +4,526,563 +10% 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 45,479,098 +2,387,176 +5.5% 31 Mar 2019 10-Q 02 May 2019 2019 Q1
Q4 2018 45,224,480 +2,839,857 +6.7% 31 Dec 2018 10-K 27 Feb 2020 2019 FY
Q3 2018 43,369,323 +7,284,057 +20% 30 Sep 2018 10-Q 31 Oct 2018 2018 Q3
Q2 2018 43,188,012 +7,123,495 +20% 30 Jun 2018 10-Q 01 Aug 2018 2018 Q2
Q1 2018 43,091,922 +7,066,246 +20% 31 Mar 2018 10-Q 01 May 2018 2018 Q1
Q4 2017 42,384,623 +6,366,083 +18% 31 Dec 2017 10-K 27 Feb 2019 2018 FY
Q3 2017 36,085,266 +90,192 +0.25% 30 Sep 2017 10-Q 31 Oct 2017 2017 Q3
Q2 2017 36,064,517 +69,443 +0.19% 30 Jun 2017 10-Q 01 Aug 2017 2017 Q2
Q1 2017 36,025,676 +33,466,921 +1308% 31 Mar 2017 10-Q 02 May 2017 2017 Q1
Q4 2016 36,018,540 +33,459,785 +1308% 31 Dec 2016 10-K 14 Mar 2018 2017 FY
Q3 2016 35,995,074 30 Sep 2016 10-Q 01 Nov 2016 2016 Q3
Q2 2016 35,995,074 30 Jun 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 2,558,755 31 Mar 2016 10-Q 03 Jun 2016 2016 Q1
Q4 2015 2,558,755 31 Dec 2015 10-K 14 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.